---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-018302"
form_type: "8-K"
ticker: "NSPR"
cik: "0001433607"
company_name: "InspireMD, Inc."
filed_at: "2025-07-09T23:59:59+00:00"
generated_at: "2026-05-18T08:52:10.360474+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# InspireMD launches CGuard Prime carotid stent system in US after FDA PMA approval

## Summary
- U.S. commercial launch of CGuard Prime carotid stent system after FDA PMA approval.
- Device features dual-layer design with MicroNet mesh (20 µm PET) and SmartFit technology.
- CEO Marvin Slosman notes double-digit market share in >30 countries; U.S. team assembled.
- First commercial case performed by Dr. D. Chris Metzger at OhioHealth; Ballad Health involved.

## SEC filing metadata
- accession: 0001641172-25-018302
- form_type: 8-K
- ticker: NSPR
- cik: 0001433607
- company_name: InspireMD, Inc.
- filed_at: 2025-07-09T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1433607/000164117225018302/0001641172-25-018302-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1433607/000164117225018302/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-018302
- JSON: https://secwatch.observer/filing/0001641172-25-018302.json
- Plain text: https://secwatch.observer/filing/0001641172-25-018302.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.